Activity value 66International Buyer&Supplier,Last transaction date:
2021-04-12
Overview
Import data
Partners
HS Codes
Products
Areas
Ports
Trade trend analysis
Mon
|
Year
Number of TransactionsQuantityWeight
Number of TransactionsQuantityWeight
The above chart presents the market trend analysis for agera pharma ag from 2020 to 2021.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2021, the company has completed 6 transactions, with a transaction quantity of 0.13 and a transaction weight of 0.09.
YearTransactionsQuantityWeight
2020000
202160.130.09
Bill of lading data
<
1/15
>
Trade date
2021/04/12
B/L No.
1056716
Suppliers
r l fine chem
Buyers
agera pharma ag
POLs
bangalore
PODs
zurich
Supply area
India
Purchas area
Switzerland
Weight
0.005kg
Amount
1183.792
Hs code
29420090
Product tags
pharmace,urit,bromide,bat,bulk drug
Product description
FA BASE(FA BROMIDE IMPURITY-A) PHARMACEU TICAL BULK DRUG BATCH NO : FA/IMP/A//WS/ 9
Expand
agera pharma ag is International Buyer&Supplier,
and primarily engages in the import and export business of products such as bat,urit,bromide.
According to the 52wmb.com global trade database, as of 2021-04-12, the company has completed 166 international trades,
with its main trading regions covering india,other etc.
The core products include HS29420090 etc,
often transported via zurich etc,
and its main trading partners are r l fine chem,mylan laboratories ltd.,тов нвц біоніка ю а київ хар ке ш 176б к 75 ф.
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on agera pharma ag is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.